Dr Iryna Kuchuk

Education:

• September 2011 – July 2013 – University of Ottawa, Faculty of Medicine, Medical Oncology Clinic, Ottawa, Ontario. Clinical Fellow in Breast Cancer. Supervisor: Dr. Mark Clemons
• 08/2011 – CITI Canada GCP Training, TCPS2 Training
• 2007 – GCP Course, Israel
• 1990-1996 – Doctor of Medicine (MD), Poltava Medical School, Ukraine

Professional Experience:

• Since December 2017 – Head of the Breast Cancer Division at the Oncology Clinic, Meir Medical Center
• Since September 2013 – Senior Oncologist at the Oncology Clinic, Meir Medical Center
• September 2011 – July 2013 – University of Ottawa, Faculty of Medicine, Medical Oncology Clinic, Ottawa, Ontario. Clinical Fellow in Breast Cancer
• 1/2009-03/2011 – Medical Oncologist, Oncology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel
• 11/2009 – Board Certification in Medical Oncology
• 2005-2009 – Residency in Oncology, Oncology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel
• 2005 – Board Certification in Internal Medicine
• 2001-2005 – Residency in Internal Medicine, Internal Medicine F, Chaim Sheba Medical Center, Tel Hashomer, Israel
• 2000-2001 – Internship, Chaim Sheba Medical Center, Tel Hashomer, Israel

Professional Memberships:

• Member of the Israeli Society of Clinical Oncology and Radiation Therapy
• Member of ASCO

Research Activity:

• Feasibility Study: Histomorphometric and Microarchitectural Analysis Using 2 mm Bone Marrow Biopsy Specimens in Patients with Metastatic Breast Cancer Treated with Long-Term Bisphosphonate Therapy
• Changes in the Relative Importance of Various Clinical Endpoints in Patients with Breast Cancer – Treatment Effects, Tumor Biology, and Symptoms – Cross-Sectional Study, Electronic Survey Study
• Randomized, Double-Blind, Placebo-Controlled Phase III Trial Evaluating the Palliative Benefits of Continuing Pamidronate or Switching to Second-Line Zoledronic Acid in Breast Cancer Patients with High-Risk Bone Metastases
• Randomized Phase IV Study of Individualized Care versus Standard Care in Preventing Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients (EPIC Study)
• Phase II Clinical Trial Evaluating the Clinical and Correlative Effects of Combining Doxycycline with Standard Bisphosphonate Therapy in Patients with Metastatic Breast Cancer (Achilles Study)
• Assessment of the Efficacy of De-escalated Bisphosphonate Therapy in Breast Cancer Patients at Low Risk of Skeletal-Related Events. TRIUMPH: A Pragmatic Multicenter Study
• Retrospective Chart Review – Incidence and Management of Bone Metastases in Patients with Advanced Breast and Prostate Cancer
• Retrospective Chart Review – Incidence and Consequences of Bone Metastases in Patients with Lung Cancer Treated in a Non-Clinical Trial Setting. Supervisor: Dr. Mark Clemons
• 2005-2010 – Collaborator in Numerous Clinical Trials on Breast Cancer, Melanoma, and Lung Cancer, Oncology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel
• 2004 – Research Project: Mutation Study in Jewish FMF Patients in Iran. Supervisor: Dr. Yael Shinar

Teaching Experience in Academic Settings:

• 06/08/201-7-2018 – Lecture for Medical Students, Tel Aviv University (Gesher Cal Program)
• 2013-2019 – Clinical Tutor for Medical Students in Medical Oncology, Tel Aviv University
• 2012-2013 – Teaching for Internal Medicine Residents, Medical Oncology Training Program, University of Ottawa
• 2008-2010 – Clinical Tutor for Medical Students in Medical Oncology
• 2004-2005 – Clinical Tutor for Internal Medicine Students

Granted Research Grants with Scientific Review:

• June 2012 – May 2015 (3 years). Canadian Breast Cancer Research Fund. Co-Investigator. Phase II Clinical Trial Evaluating the Clinical and Correlative Effects of Combining Doxycycline with Standard Bisphosphonate Therapy in Patients with Metastatic Breast Cancer (Achilles Study).

Academic and Professional Awards:

• 2009/2010 – Sheba Medical Center Award for Outstanding Achievements in Clinical Activity Advisory Boards:
• 2015, 2016 – Pfizer
• 2019 – Novartis

Patient Interaction in Languages:

• Russian
• English
• Hebrew